Zydus Cadila has received the final approval from the USFDA to market Chlorthalidone Tablets USP (US RLD – THALITONE®), 25 mg and 50 mg. Chlorthalidone is used to treat high blood pressure (hypertension). It is also used to treat fluid retention (edema) in people with congestive heart failure, cirrhosis of the liver or kidney disorders or edema caused by taking steroids or estrogen. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad. The group now has 266 approvals and has so far filed over 350 ANDAs since the commencement of the filing process in FY 2003-04.
top of page
Search
Recent Posts
See AllThe diabetic population in the country is close to hitting the alarming mark of 69.9 million by 2025, which denotes that the country is...
bottom of page